Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Cirrhosis”

278 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 278 results

Not applicableStudy completedNCT01701687
What this trial is testing

Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease

Who this might be right for
Alcoholic Liver DiseasesDecompensated Cirrhosis
University of Nottingham 36
Not applicableStudy completedNCT02679417
What this trial is testing

The Effects of Type of Exercise in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Mahidol University 38
Not applicableStudy completedNCT02083367
What this trial is testing

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

Who this might be right for
Hepatic EncephalopathyCirrhosisNonalcoholic Steatohepatitis+1 more
OSF Healthcare System 12
Not applicableStudy completedNCT03198104
What this trial is testing

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI

Who this might be right for
Non-alcoholic SteatohepatitisLiver DiseasesLiver Fibroses+2 more
Perspectum 35
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Not applicableUnknownNCT05971082
What this trial is testing

Risk Factors for Advanced Fibrosis Among FLD Patients

Who this might be right for
NAFLDLiver CirrhosisDiabetes Mellitus, Type 2
Helsinki University Central Hospital 1,000
Not applicableActive Not RecruitingNCT03158818
What this trial is testing

Chronic Hepatitis B Virus Infection in Zambia

Who this might be right for
HBVFibrosis, LiverCirrhosis, Liver+3 more
University of Alabama at Birmingham 326
Not applicableLooking for participantsNCT07294963
What this trial is testing

Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNeurocognitive Disorders
Khyber Medical University Peshawar 45
Not applicableLooking for participantsNCT04036357
What this trial is testing

Liver Damage and Cardiometabolic Disorders in NAFLD

Who this might be right for
NAFLDLiver FibrosesCardiovascular Diseases+1 more
University of Roma La Sapienza 2,000
Not applicableLooking for participantsNCT05257200
What this trial is testing

Gut Permeability and Bariatric-metabolic Surgery

Who this might be right for
NASH - Nonalcoholic SteatohepatitisBariatric Surgery CandidateIntestinal Permeability
Medical University of Vienna 125
Large-scale testing (Phase 3)Study completedNCT00244569
What this trial is testing

Development of a Breath Test for Monitoring Patients With Liver Disease

Who this might be right for
Fatty LiverCirrhosis
Virginia Commonwealth University 120
Not applicableStudy completedNCT05383456
What this trial is testing

The Visceral Adiposity Measurement and Observation Study

Who this might be right for
HIVHIV-InfectionsHIV-1-infection+16 more
Theratechnologies 196
Testing effectiveness (Phase 2)Ended earlyNCT01672866
What this trial is testing

Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 222
Testing effectiveness (Phase 2)Ended earlyNCT02029586
What this trial is testing

Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis

Who this might be right for
Nonalcoholic Fatty Liver Disease
Yungjin Pharm. Co., Ltd. 18
Post-approval studies (Phase 4)Ended earlyNCT00188045
What this trial is testing

Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients

Who this might be right for
Alcoholic Cirrhosis
University Hospital, Angers 54
Very early researchStudy completedNCT02326103
What this trial is testing

Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis

Who this might be right for
Alcoholic HepatitisAlcoholic Cirrhosis
University of Helsinki 22
Post-approval studies (Phase 4)Looking for participantsNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Not applicableEnded earlyNCT02811887
What this trial is testing

SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy

Who this might be right for
Liver Cirrhosis, Alcoholic
Marius Henriksen 9
Testing effectiveness (Phase 2)Ended earlyNCT04267393
What this trial is testing

Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Bristol-Myers Squibb 124
Early research (Phase 1)Study completedNCT04857437
What this trial is testing

Study in Healthy Adults Evaluating PF-07202954

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver Fibrosis
Pfizer 12
Load More Results